Pfizer Makes Vaccines Entry With PowderMed Acquisition
Acquisition of the U.K. company will give Pfizer a pipeline of DNA-based vaccines that could surpass cell-based technology, firm says.
Acquisition of the U.K. company will give Pfizer a pipeline of DNA-based vaccines that could surpass cell-based technology, firm says.